METROPOLIS.NS Live-Signale | Maximieren Sie Profite mit Getagraph.com

Live Chart Being Loaded With Signals

Commentary (26 Apr 2024 @ 11:59):

Stats
Tagesvolumen	210 126
Durchschnittsvolumen	385 687
Marktkapitalisierung	92.47B
EPS	INR0 ( 2024-02-04 )
Nächstes Ertragsdatum	( INR13.40 ) 2024-05-13
Last Dividend	INR8.00 ( 2023-02-23 )
Next Dividend	INR0 ( N/A )
P/E	74.37
ATR14	INR2.05 (0.11%)

Volumen Korrelation

Lang: -0.08 (neutral)

Kurz: 0.52 (weak)

Signal:(46.517) Neutral

Metropolis Healthcare Korrelation

10 Am meisten positiv korreliert

10 Am meisten negativ korreliert

Wussten Sie das?

Korrelation ist ein statistisches Maß, das die Beziehung zwischen zwei Variablen beschreibt. Es reicht von -1 bis 1, wobei -1 eine perfekte negative Korrelation (wenn eine Variable zunimmt, nimmt die andere ab) anzeigt, 1 eine perfekte positive Korrelation (wenn eine Variable zunimmt, nimmt die andere zu) und 0 keine Korrelation anzeigt (es besteht kein Zusammenhang zwischen den Variablen).

Korrelation kann verwendet werden, um die Beziehung zwischen beliebigen zwei Variablen zu analysieren, nicht nur zwischen Aktien. Es wird häufig in Bereichen wie Finanzen, Wirtschaft, Psychologie und mehr verwendet.

Metropolis Healthcare Korrelation - Währung/Rohstoff

-0.19
( neutral )

-0.43
( neutral )

0.08
( neutral )

-0.07
( neutral )

-0.31
( neutral )

-0.06
( neutral )

Metropolis Healthcare Finanzdaten

Annual	2022
Umsatz:	INR11.48B
Bruttogewinn:	INR8.88B (77.37 %)
EPS:	INR27.91

FY	2022
Umsatz:	INR11.48B
Bruttogewinn:	INR8.88B (77.37 %)
EPS:	INR27.91

FY	2022
Umsatz:	INR12.28B
Bruttogewinn:	INR9.41B (76.59 %)
EPS:	INR41.87

FY	2021
Umsatz:	INR9.98B
Bruttogewinn:	INR7.38B (73.92 %)
EPS:	INR35.97

Financial Reports:

No articles found.

Metropolis Healthcare Dividends

(Q3/22)	(Q4/22)	(Q1/23)	(Q2/23)	(Q3/23)	(Q4/23)	(Q1/24)	(Q2/24)	(Q3/24)	(Q4/24)
INR0 (N/A)	INR0 (N/A)	INR8.00 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)

Metropolis Healthcare Dividend Information - Dividend Junior

Dividend Sustainability Score: 3.98 - low (32.22%) | Divividend Growth Potential Score: 3.79 - Decrease likely (24.28%)

Very Unsafe

High risk of being cut

Unsafe

Heightened risk of being cut

Borderline

Moderate risk of being cut

Safe

Unlikely to be cut

Very Safe

Very unlikely to be cut

Information

First Dividend	INR8.00	2020-02-13
Last Dividend	INR8.00	2023-02-23
Next Dividend	INR0	N/A
Payout Date	0000-00-00
Next Payout Date	N/A
# dividends	4	--
Total Paid Out	INR32.00	--
Avg. Dividend % Per Year	0.30%	--
Score	1.82	--
Div. Sustainability Score	3.98
Div.Growth Potential Score	3.79
Div. Directional Score	3.88	--

Next Divdend (Est)
(2024-12-31)

INR0 Estimate 0.00 %

Dividend Stability

0.06 Very Bad

Dividend Score

1.82

Pay Frequency

Annually

Yearly Payout

Year	Amount	Yield
2020	INR8.00	0.56%
2021	INR8.00	0.40%
2022	INR8.00	0.23%
2023	INR8.00	0.61%
2024	INR0	0.00%

Dividend Commentary

The company's low Dividend Sustainability Score (DSS) highlights potential challenges in upholding its current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. In conclusion, a more vigilant stance is recommended given the company's tentative dividend landscape.

Top 10 dividend Companies for NSE

Symbol	Title	Last dividend	Frequency	Years Dividend	Yearly Dividend
SARDAEN.NS	Dividend Junior	2023-09-07	Annually	15	0.65%
MAGADSUGAR.NS	Dividend Junior	2023-07-13	Annually	7	1.78%
GMDCLTD.NS	Dividend Knight	2023-09-22	Annually	23	3.41%
ASTRAMICRO.NS	Dividend Junior	2023-08-23	Annually	20	0.49%
TITAN.NS	Dividend Junior	2023-07-13	Annually	20	0.35%
PETRONET.NS	Dividend Knight	2023-08-18	Semi-Annually	18	2.36%
JASH.NS	Dividend Junior	2023-09-22	Annually	7	0.57%
DBOL.NS	Dividend Junior	2023-06-23	Insufficient data to determine frequency	2	0.56%
SILINV.NS	Dividend Junior	2023-08-18	Annually	23	0.63%
MBAPL.NS	Dividend Junior	2023-09-18	Annually	8	0.44%

Dividend Sustainability Score (DSS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
netProfitMarginTTM	0.108	1.500	7.85	10.00	[0 - 0.5]
returnOnAssetsTTM	0	1.200	0	0	[0 - 0.3]
returnOnEquityTTM	0.122	1.500	9.75	10.00	[0.1 - 1]
payoutRatioTTM	0	-1.000	0	0	[0 - 1]
currentRatioTTM	0	0.800	-5.00	-4.00	[1 - 3]
quickRatioTTM	0	0.800	-4.71	-3.76	[0.8 - 2.5]
cashRatioTTM	0	1.500	-1.111	-1.667	[0.2 - 2]
debtRatioTTM	0	-1.500	0	0	[0 - 0.6]
interestCoverageTTM	8.18	1.000	8.08	8.08	[3 - 30]
operatingCashFlowPerShareTTM	35.72	2.00	10.00	10.00	[0 - 30]
freeCashFlowPerShareTTM	35.72	2.00	10.00	10.00	[0 - 20]
debtEquityRatioTTM	0	-1.500	0	0	[0 - 2.5]
grossProfitMarginTTM	0.791	1.000	0.155	0.155	[0.2 - 0.8]
operatingProfitMarginTTM	0.163	1.000	8.74	8.74	[0.1 - 0.6]
cashFlowToDebtRatioTTM	0	1.000	-1.111	-1.111	[0.2 - 2]
assetTurnoverTTM	0	0.800	-3.33	-2.67	[0.5 - 2]
Total Score				3.98

Dividend Growth Score (DGS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
peRatioTTM	74.11	1.000	2.62	0	[1 - 100]
returnOnEquityTTM	0.122	2.50	9.84	10.00	[0.1 - 1.5]
freeCashFlowPerShareTTM	35.72	2.00	10.00	10.00	[0 - 30]
dividendYielPercentageTTM	0.222	1.500	4.46	0	[0 - 0.4]
operatingCashFlowPerShareTTM	35.72	2.00	10.00	10.00	[0 - 30]
payoutRatioTTM	0	1.500	0	0	[0 - 1]
pegRatioTTM	-2.22	1.500	-10.00	0	[0.5 - 2]
operatingCashFlowSalesRatioTTM	0.158	1.000	8.55	0	[0.1 - 0.5]
Total Score				3.79

Metropolis Healthcare

Metropolis Healthcare Limited provides diagnostic services in India. It offers clinical laboratory testing, and profiles and support services. The company provides diagnostic services for oncology, neurology, gynecology, and nephrology, as well as various health check-up packages for men, women, senior citizens, and youth and corporates. Its tests and profiles are used for prediction, early detection, diagnostic screening, confirmation, and/or monitoring of the disease. The company also offers corporate wellness and hospital laboratory solutions, as well as clinical research services. As of March 31, 2022, it operated 171 clinical laboratories, 9,000 pick-up points, and 704 assisted referral centers. The company was founded in 1980 and is headquartered in Mumbai, India.